
Injectables vs Surgery: How Patients Are Rethinking Facial Ageing
For two decades, the default response to an ageing face was an injection. Botulinum toxin softened lines, and fillers restored volume. Now many patients who started in their thirties are asking a different question, which is whether years of injections have done what they hoped, or whether the problem is one that only surgery can address.
What injectables do well
Injectables have clear strengths. Botulinum toxin relaxes the muscles that cause frown and forehead lines, and the effect fades in a few months. Fillers add volume to cheeks, lips and folds. Both need no operation, little downtime and no general anaesthetic, which is why they dominate the market.
A survey of members of the American Academy of Facial Plastic and Reconstructive Surgery, reported in the trade press, found that non-surgical treatments account for about 80 percent of the procedures its surgeons perform. Convenience explains much of that. Dr Jonathan Dunne's practice examines where injectables fit and when surgery may better address facial ageing.
For early ageing, injectables are often the right tool. They suit people whose main change is volume loss or expression lines, and they allow a patient to try an idea before committing to anything permanent. Injectables also have a role after surgery, where small touch-ups to the lips, chin or lines can complement a lifted face. The question is therefore not which approach is better in general, but which is better for the concern you have.
Read the article at https://jonathan-dunne.com/blog/why-facelifts-are-replacing-fillers/.
Where injectables reach their limits
The limit comes when the problem is tissue that has descended, not volume that has been lost. Jowls, a heavy jawline and neck laxity reflect loosened deeper layers and surplus skin. Adding filler to a sagging face adds weight, and it can blur the contour instead of restoring it.
Surgeons who describe the trend generally make the same point, in plain terms, that fillers restore volume while a facelift addresses tissue descent, laxity and jawline definition.
Repeated treatments add up in cost over the years, and maintenance never ends. A patient who spends several hundred pounds twice a year for a decade may have spent as much as a surgical procedure, with less durable change. Over-filling is a further risk, and a common one, because chasing volume in several areas can alter proportions and leave the face looking heavy or unnatural. A patient who has had filler in several places should tell the surgeon, since it can affect planning.
Safety and regulation of non-surgical treatment
Injectables are not risk-free. The NHS explains in its guidance on dermal fillers that having fillers is usually safe if done by an experienced and suitably qualified practitioner, that the risks depend on whether the procedure was done correctly and the type of filler used, and that serious problems are rare.
It lists those serious problems as infection, a lumpy appearance under the skin that may need treatment, filler moving from the intended area, scarring and blocked blood vessels in the face, which can cause tissue death and permanent blindness. Early symptoms such as severe pain, pale or mottled skin, or a vision change need urgent medical help.
Choose a practitioner with medical training and a clear plan for complications, ask what product will be used and avoid any treatment offered as a party or a prize.
Regulation is changing but remains patchy. Cosmetic injections to anyone under 18 are an offence in England, and the Royal College of Surgeons has long argued that fillers should be treated more like prescription medicines and given only by suitably qualified practitioners. For patients the practical rules are simple. Ask who will inject and what their training is, check that products are approved, find out what happens if something goes wrong and never feel pressured to decide on the day.
What surgery adds, and what it costs
A facelift repositions deeper tissue, removes surplus skin and redefines the jaw and neck. It is a bigger step with a general or local anaesthetic, a recovery of two weeks or more and risks that include bleeding, nerve injury and scarring. Its effect lasts longer than injectables, though ageing continues.
Cost is a different calculation. Surgery costs more at first and less over time, but the comparison is not simple, because many patients combine procedures and still use some injectables afterward. A surgeon should give a clear estimate that covers the operation, anaesthesia, hospital fees and follow-up.
Surgery also demands a stronger decision. Professional standards recommend consent in two stages with at least two weeks to reflect, and a patient should feel free to take longer. A short list of questions for a surgeon includes how often they perform the operation, how they handle complications and what their revision policy is, and the answers should be given in writing.
Making the choice
Start by naming the problem. If it is volume, lines or lips, injectables may be enough. If it is jowls, a slack neck or heaviness of the lower face, surgery is more likely to help. Many people have a mixture, and a consultant who offers both can compare them honestly.
Ask each practitioner what they would do if the choice were theirs, what the alternatives are and what would happen if you did nothing. Be cautious of anyone who recommends only the treatment they sell.
Whichever route you choose, plan for maintenance. Injectables need repeating, surgery needs good skin care and sun protection afterward and both work best on a healthy, stable foundation. Do not forget the basics that protect any result. Sun protection, not smoking, steady weight and good sleep slow visible ageing more than any procedure, and they cost little. Surgeons and injectors alike will tell you that patients who look after their skin need less intervention and keep results for longer.

